Live
- ‘Jathara’ movie review: A rural revenge saga wrapped in tradition
- PM Modi’s ‘Bharat 6G Vision’ poised to get another booster
- Social media doing harm to youngsters, calling time on it: Australian PM Albanese
- Gut microbiome changes may signal onset of rheumatoid arthritis
- Caste census, a historic benchmark in country: MLA Prakash
- Siddharth and Ashika Ranganath’s ‘Miss You’ Set for November 29 Release
- Cops return kidnapped woman within 24 hours
- IT Min lays foundation stone for Co-operative Central Bank building
- Abhishek Bachchan and Aishwarya Rai Divorce Rumors: Family Denies Affair with Nimrat Kaur
- MLA Naini Rajender lauds Comprehensive Family Survey
Sun Pharma drops 7.5 per cent on Sebi report
Highlights
Shares of Sun Pharmaceutical Monday dived 75 per cent after reports that markets regulator Sebi may reopen an insider trading case against the firm and probe alleged lapses by some of its promoters The companys shares fell 752 per cent to end at Rs 45530 apiece on the BSE
​New Delhi: Shares of Sun Pharmaceutical Monday dived 7.5 per cent after reports that markets regulator Sebi may reopen an insider trading case against the firm and probe alleged lapses by some of its promoters. The company's shares fell 7.52 per cent to end at Rs 455.30 apiece on the BSE.
During the day, the stock declined 10.22 per cent to Rs 441.95. On the NSE, the scrip of the company slumped by 7.53 per cent to close at Rs 455.50. In terms of volume, over 48 lakh shares were traded on the BSE, while over 6 crore units changed hands on the NSE.
Next Story
ADVERTISEMENT
